[EN] HETEROCYCLIC BENZOXAZOLE COMPOSITIONS AS INHIBITORS OF HEPATITIS C VIRUS [FR] COMPOSITIONS HÉTÉROCYCLIQUES DE BENZOXAZOLE À TITRE D'INHIBITEURS DU VIRUS DE L'HÉPATITE C
[EN] HETEROCYCLIC BENZOXAZOLE COMPOSITIONS AS INHIBITORS OF HEPATITIS C VIRUS [FR] COMPOSITIONS HÉTÉROCYCLIQUES DE BENZOXAZOLE À TITRE D'INHIBITEURS DU VIRUS DE L'HÉPATITE C
Heterocyclic Benzoxazole Compositions as Inhibitors of Hepatitis C Virus
申请人:Smith Paul
公开号:US20120208856A1
公开(公告)日:2012-08-16
This invention relates to benzoxazole compounds, compositions and devices for delivering them, processes for manufacturing them, and methods of using them in the treatment of Hepatitis C Virus.
Heterocyclic benzoxazole compositions as inhibitors of hepatitis C virus
申请人:Smith Paul
公开号:US08822515B2
公开(公告)日:2014-09-02
This invention relates to benzoxazole compounds, compositions and devices for delivering them, processes for manufacturing them, and methods of using them in the treatment of Hepatitis C Virus.
[EN] HETEROCYCLIC BENZOXAZOLE COMPOSITIONS AS INHIBITORS OF HEPATITIS C VIRUS<br/>[FR] COMPOSITIONS HÉTÉROCYCLIQUES DE BENZOXAZOLE À TITRE D'INHIBITEURS DU VIRUS DE L'HÉPATITE C
申请人:UNIV MARYLAND
公开号:WO2011047390A3
公开(公告)日:2011-10-20
US8822515B2
申请人:——
公开号:US8822515B2
公开(公告)日:2014-09-02
UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication
作者:Dawn N. Ward、Daniel C. Talley、Mrinalini Tavag、Samrawit Menji、Paul Schaughency、Andrea Baier、Paul J. Smith
DOI:10.1016/j.bmcl.2013.12.012
日期:2014.1
The bacterial natural product UK-1 and several structural analogs inhibit replication of the hepatitis C virus in the replicon assay, with IC50 values as low as 0.50 mu M. The NS3 helicase has been identified as a possible target of inhibition for several of these compounds, while the remaining inhibitors act via an undetermined mechanism. Gel shift assays suggest that helicase inhibition is a direct result of inhibitor-enzyme binding as opposed to direct RNA binding, and the ATPase activity of NS3 is not affected. The syntheses and biological results are presented herein. (C) 2013 Elsevier Ltd. All rights reserved.